Unlocking Novel Autoimmune Therapeutic Opportunities Through Precision Peptide-HLA Target Discovery & Immune Modulation
- Leveraging advanced peptide-HLA discovery platforms to identify disease-driving antigens and previously inaccessible targets, expanding the range of therapeutic opportunities beyond conventional immune-cell surface markers
- Exploring multiple strategies for selectively targeting peptide-HLA complexes, including T-cell engagers and other precision immune-modulating approaches, to enhance specificity while minimizing off-target immune effects
- Presenting case studies highlighting the discovery, validation, and therapeutic potential of novel peptide-HLA targets, demonstrating how precision antigen recognition can enable the next generation of autoimmune disease therapies